Shares

18 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 09, 2024

SELL
$30.43 - $53.43 $211,731 - $371,765
-6,958 Reduced 34.71%
13,089 $527,000
Q1 2024

May 06, 2024

BUY
$22.09 - $35.41 $442,838 - $709,864
20,047 New
20,047 $709,000
Q3 2023

Nov 07, 2023

SELL
$19.33 - $36.22 $1.08 Million - $2.03 Million
-56,126 Reduced 83.02%
11,482 $238,000
Q2 2023

Aug 08, 2023

SELL
$24.18 - $42.46 $91,303 - $160,328
-3,776 Reduced 5.29%
67,608 $1.66 Million
Q1 2023

May 12, 2023

SELL
$35.86 - $46.5 $32,955 - $42,733
-919 Reduced 1.27%
71,384 $2.9 Million
Q4 2022

Feb 13, 2023

BUY
$35.49 - $56.15 $2.57 Million - $4.06 Million
72,303 New
72,303 $3.25 Million
Q2 2022

Aug 09, 2022

BUY
$53.22 - $123.09 $1.9 Million - $4.39 Million
35,633 Added 640.42%
41,197 $2.44 Million
Q1 2022

May 16, 2022

BUY
$101.89 - $150.09 $517,499 - $762,307
5,079 Added 1047.22%
5,564 $647,000
Q4 2021

Feb 11, 2022

BUY
$118.18 - $153.21 $57,317 - $74,306
485 New
485 $73,000
Q1 2021

May 14, 2021

SELL
$81.28 - $104.34 $1.56 Million - $2 Million
-19,164 Closed
0 $0
Q4 2020

Feb 12, 2021

BUY
$86.4 - $121.75 $1.43 Million - $2.02 Million
16,594 Added 645.68%
19,164 $1.83 Million
Q3 2020

Nov 16, 2020

BUY
$95.43 - $116.09 $245,255 - $298,351
2,570 New
2,570 $291,000
Q2 2020

Aug 13, 2020

SELL
$60.05 - $98.92 $140,096 - $230,780
-2,333 Closed
0 $0
Q1 2020

May 13, 2020

SELL
$47.37 - $90.04 $229,033 - $435,343
-4,835 Reduced 67.45%
2,333 $150,000
Q4 2019

Feb 10, 2020

BUY
$53.13 - $71.19 $380,835 - $510,289
7,168 New
7,168 $427,000
Q3 2019

Nov 12, 2019

SELL
$57.11 - $73.3 $1.67 Million - $2.15 Million
-29,310 Closed
0 $0
Q2 2019

Aug 13, 2019

BUY
$54.41 - $71.7 $1.56 Million - $2.06 Million
28,679 Added 4545.01%
29,310 $1.89 Million
Q1 2019

May 13, 2019

BUY
$32.25 - $73.56 $20,349 - $46,416
631 New
631 $40,000

Others Institutions Holding TNDM

About TANDEM DIABETES CARE INC


  • Ticker TNDM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 64,221,200
  • Market Cap $2.38B
  • Description
  • Tandem Diabetes Care, Inc., a medical device company, designs, develops, and commercializes various products for people with insulin-dependent diabetes in the United States and internationally. The company's flagship product is the t:slim X2 insulin delivery system, a pump platform that comprises t:slim X2 pump, its 300-unit disposable insulin c...
More about TNDM
Track This Portfolio

Track Quantbot Technologies LP Portfolio

Follow Quantbot Technologies LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Quantbot Technologies LP, based on Form 13F filings with the SEC.

News

Stay updated on Quantbot Technologies LP with notifications on news.